Join the DDA or

New EpiPen AAI advice

Patients can now hold two in-date AAIs

November 7th 2018

Tagged: Clinical guidance news Dispensary guidance news

By Ailsa Colquhoun

The Department of Health has revised its guidance for prescribing 150mcg adrenaline auto-injectors (AAIs), in light of an improving stock position.

In the new advice, which applies throughout the UK, prescribers can ensure that every patient has at least two 150microgram adrenaline auto injectors that are either in date or have a formally extended expiry date – see listed batches.

The validation protocol has been revised to reflect the improving supply position, while managing the prescription backlog.

A revised Q&A has also been published.

For all the latest news of the 2018 DDA annual conference...

Learn more